Leukemia & Lymphoma Society of Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
60%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 60 cents are available for programs.
My anchor
OVERVIEW
About Leukemia & Lymphoma Society of Canada:
Leukemia & Lymphoma Society of Canada is a 3-star charity with an average results reporting grade. It is financially transparent. Leukemia & Lymphoma Society's overhead costs are outside Ci's reasonable range.
Founded in 1955, Leukemia & Lymphoma Society of Canada (LLSC)'s mission is to support blood cancer patients and their families. The charity started due to a lack of focus on leukemia research. LLSC states that blood cancer currently effects over 155,000 Canadians. Leukemia & Lymphoma Society achieves its mission through Research, Patient Support, and Public Education.
Research represented 52% of program spending in F2022. LLSC invested $5.3m in research in F2022. It distributed 41 new grants and supported a total of 93 blood cancer researchers. During F2022, Leukemia & Lymphoma Society started five partnerships and one clinical trial.
Patient Support accounted for 25% of program spending in F2022. The charity hosts virtual support sessions with mental health professionals for patients. During F2022, 517 people attended these sessions. Overall, LLSC helped connect 3,520 patients with information and psychological support. It also distributed 462 transportation subsidies to cover hospital parking costs.
Public Education received 23% of program spending in F2022. LLSC hosted a free conference for 1,340 participants to learn about the long-term effects of blood cancer. The charity's covid-19 Resource Centre helped 4,029 patients during F2022. The Public Education program also includes helping healthcare providers continue their education. In F2022, providers completed 920 training modules on LLSC’s continuing education platform.
My anchor
Results and Impact
Charity Intelligence found that Leukemia & Lymphoma Society of Canada reported many stories but few results on its work. In the last five year, the charity has had 34 indications for blood cancer approved by Health Canada. It hopes that this will contribute to improved treatments for this disease.
While Ci highlights these key results, they may not be a complete representation of Leukemia & Lymphoma Society of Canada’s results and impact.
My anchor
Finances
Leukemia & Lymphoma Society of Canada had donations of $15.6m in F2022. The charity received $144k in government funding representing 1% of total revenues. Administrative costs are 14% of revenues (less investment income) and fundraising costs are 26% of donations. This results in total overhead spending of 40%. For every dollar donated, 60 cents go to the cause. This is outside of Ci’s reasonable range for overhead spending. LLSC has been outside of this range for almost every year of Ci’s analysis.
LLSC has $13.9m in funding reserves, of which $260k is donor endowed. Excluding donor-endowed funds, the charity could cover around one year and seven months of annual program costs with current reserves.
This charity report is an update that has been sent to Leukemia & Lymphoma Society of Canada for review. Changes and edits may be forthcoming.
Updated on June 2, 2023 by Clive Stevens.
Financial Review
Fiscal year ending June
|
2022 | 2021 | 2020 |
|---|---|---|---|
| Administrative costs as % of revenues | 13.5% | 12.6% | 13.8% |
| Fundraising costs as % of donations | 26.2% | 26.6% | 30.5% |
| Total overhead spending | 39.7% | 39.2% | 44.3% |
| Program cost coverage (%) | 155.9% | 197.8% | 261.9% |
Summary Financial StatementsAll figures in $000s |
2022 | 2021 | 2020 |
|---|---|---|---|
| Donations | 15,590 | 12,996 | 12,206 |
| Government funding | 144 | 777 | 580 |
| Investment income | (443) | 1,157 | (6) |
| Other income | 0 | 4 | 20 |
| Total revenues | 15,291 | 14,933 | 12,800 |
| Program costs | 5,047 | 4,372 | 4,119 |
| Grants | 3,735 | 2,859 | 368 |
| Administrative costs | 2,128 | 1,737 | 1,765 |
| Fundraising costs | 4,082 | 3,451 | 3,723 |
| Total spending | 14,993 | 12,419 | 9,974 |
| Cash flow from operations | 299 | 2,515 | 2,825 |
| Capital spending | 124 | 315 | 153 |
| Funding reserves | 13,930 | 14,537 | 11,976 |
Note: To report on a cash basis, Ci adjusted donations by changes in deferred revenue from non-government sources. This affected revenues by ($454k) in F2022, $404k in F2021, and ($75k) in F2020. The audited financial statements report direct research expenses and allocated research expenses. Direct research expenses are reported as grants and allocated research expenses are included in program costs. The audited financial statements include direct event fundraising costs as a reduction in revenue. Ci has made adjustments to include this cost in fundraising expenses. As a result, both revenues and expenses increased by $445k in F2022, $262k in F2021, and $778k in F2020. For investment income, Ci removed the investment management fees, impacting both revenues and expenses by ($46k) in F2022, ($41k) in F2021, and ($50k) in F2020. Ci removed amortization of capital assets on a pro-rata basis from program, administrative and fundraising costs. An adjustment was made to grants reflecting the change to Grants and Fellowship payable year over year. This affected total expenses by ($1.4m) in F2022, $1.7m in F2021, and ($131k) in F2020.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
1 |
$160k - $200k |
1 |
$120k - $160k |
7 |
$80k - $120k |
1 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2022
My anchor
Comments & Contact
Comments added by the Charity:
Below are comments added by the charity for a past profile. New comments made by the charity for this updated profile may be forthcoming:
The Leukemia & Lymphoma Society of Canada (LLSC) expanded its mission in 2005 to include patient education, support and programs in addition to the research projects that had been funded since our inception in 1955. This effort, which included the addition of Social Workers and/or Oncology Nurses to support patients to our staff team, has gradually spread out across Canada and continues to grow to this present day. At the same time, it was decided that LLSC should increase its geographical reach outside of Vancouver, Calgary and Toronto so we could offer support coast-to-coast. In the last few years, we have added in stages staffed offices in Montreal, Edmonton, Saskatoon, Ottawa, Quebec City and Halifax (as of January, 2011) to meet this mandate. LLSC has also made a concerted effort to provide all materials and programming in both official languages, which were previously only available in English. These projects involve large expenditures up front, but were deemed crucial to our ability to properly meet our mission across Canada. We are proud LLSC is now truly a national organization that can help Canadians coast-to-coast through their journey with blood cancer and also give them hope for a healthy future by funding top-notch research.
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 1-833-222-4884